Free Trial

Xeris Biopharma (XERS) SEC Filings & 10K Form

Xeris Biopharma logo
$3.23
+0.01 (+0.31%)
(As of 11/1/2024 ET)

Recent Xeris Biopharma SEC Filings

DateFilerForm TypeView
08/13/2024
3:15 PM
Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
5:28 PM
Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:27 PM
Xeris Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2024
6:15 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2024
4:22 PM
McCulloch Kevin (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
4:22 PM
Shannon John Patrick Jr (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
6:14 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:15 PM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:18 PM
HALKUFF DAWN (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:18 PM
Kong Garheng (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:18 PM
PERSKY MARLA (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:18 PM
JOHNSON JOHN (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:19 PM
BORMANN-KENNEDY BARBARA-JEAN ANNE (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:19 PM
SHERMAN JEFFREY W (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:19 PM
Fairley Ricki Louise (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:19 PM
Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:19 PM
Xeris Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:14 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
3:32 PM
Xeris Biopharma (Filer)
Form ARS
04/23/2024
3:24 PM
Xeris Biopharma (Filer)
Form DEF 14A
04/23/2024
3:26 PM
Xeris Biopharma (Filer)
Form DEFA14A
04/11/2024
3:05 PM
SHERMAN JEFFREY W (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
4:43 PM
JOHNSON JOHN (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
4:45 PM
Kong Garheng (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:32 PM
JOHNSON JOHN (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
8:03 PM
Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:19 PM
Xeris Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2024
6:27 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
4:04 PM
Edick Paul R (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:04 PM
Hecht Beth (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:04 PM
JOHNSON KENNETH ERLAND (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:05 PM
Shannon John Patrick Jr (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:05 PM
Pieper Steven (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
6:09 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2023
3:16 PM
Pieper Steven (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:20 PM
HALKUFF DAWN (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
5:35 PM
Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
4:58 PM
Shannon John Patrick Jr (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
6:20 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:XERS) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners